Blog Layout
ADCR article on uses and priorities published in Chemical Watch
ADCR article on uses and priorities published in Chemical Watch
Another article on the ADCR was published in Chemical Watch on 10 October 2019.
Following the successful launch of the ADCR Consortium in Brussels on 20 September 2019, Chemical Watch reports on the next steps, which are to define the scope of the authorisation applications and to set the first priorities for the work of the Consortium.
Initial scoping work is mapping the possible uses in the Aerospace and Defence (A&D) sector of the eight chromates under consideration. This Consortium is unique in that it focuses only on the chromates authorisation requirements for the A&D sector.
Steve George, Chair of the ADCR, is quoted as saying: "It may be that the number of specific applications underneath this umbrella of uses goes down significantly ... maybe one of the substances has been substituted by some companies for newer products, while other companies cannot substitute and may need to prepare applications”.
During the launch meeting Matti Vainio, ECHA’s head of risk assessment, gave a presentation to the A&D stakeholders. The Chemical Watch article also quotes Mr Vainio as saying that it is positive that stakeholders in the A&D sector are looking to "see what kind of substitution can take place and where they need to prepare authorisation reviews".
The ADCR is open to new founding members joining the Consortium, with a deadline of 20 December 2019.
For access to the article, see here: https://chemicalwatch.com/83099/aerospace-and-defence-reauthorisation-consortium-identifies-chromates-uses
Other news items:
ADCR has developed a concise document presenting the main aspects of the 21 Dossiers submitted in EU and UK. The Factual Communication summarises the content of the dossiers, and provides information on the Chemical Safety Report, Analysis of Alternatives, research/substitution plans and the Socioeconomic analysis. Key facts are provided in bullet points and the timeline of upcoming authorisation decisions is provided. Authorisations are needed to ensure the continued availability and operation of A&D products in the EEA, since Cr(VI) is still required for manufacture, maintenance, repair and overhaul across the sector. Viable alternatives for every impacted part and process, where Cr(VI) is currently necessary, are not yet available, despite ongoing efforts. ADCR Factual Communication (pdf, 16 July 2024)